Most likely not in the exact same pen like fashion, but maybe something close. Semaglutide & Tirzepatide (Mounjaro) are the chemicals & there's no need for them to be as scarce as they currently are. The only reason we got put in this situation is because the companies trademarked the *exact same drug* for different use cases & trademarked the administration vessel to intentionally control the market and cause an increase in cost.

It's why it was ruled that despite the patent/trademarks that due to the scarcity other compounding pharmacies can make Semaglutide & Tirzepatide, Americans simply need it too badly to keep it locked up with those initial companies.

It is also incredibly expensive to go with the brand names & their trade marked administration methods. For perspective, many people pay $700-1,400 a month for one of the brand named /trademarked systems of Semaglutide. The medication itself from compounding pharmacies (the exact same thing) can cost 3-7 times less & you can inject it yourself. It costs maybe $2 for 1 month worth of injection supplies. 4 syringes, 4 needles, a few alcohol prep pads. You can do it just fine, don't let yourself get fooled into paying an extra $500-900 for 4 syringes in a pretty looking stick.